PODCAST | Finance
East-West Summit Highlights: a BioCentury podcast
Zhaoke’s Lisa Feng, Jones Day’s Tony Chen and Paul Hastings’ Phoebe Yan discuss challenges faced by cross-border biotechs
Cash conversation and sticking to priorities are essential for China’s biotechs as they navigate today’s gloomy funding environment, Zhaoke’s Lisa Feng said on BioCentury This Week. On a special East-West Summit edition of the podcast, Feng, who is CBO and CFO of Zhaoke Ophthalmology Ltd. (HKEX:6622), Jones Day’s Tony Chen and Paul Hastings’ Phoebe Yan joined the BioCentury podcast team to discuss challenges of compliance risk in a digital world, China’s value-based procurement and IP landscape, and the environment for IPOs and licensing deals for China’s biotechs.
BCIQ Company Profiles